BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld Asia
Home
» Other news to note for April 7, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for April 7, 2020
April 7, 2020
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Adaptive, Alnylam, Amgen, Ansun, Assembly, Astellas, Aurobindo, Bioaegis, Bioardis, Bionomics, Brii, Capricor, Carterra, Celltrion, Celularity, Cytodyn, Diffusion, Eisai, Ennaid, Evotec, Evqlv, Flexion, Flugen, GSK, Ildong, Incyte, Innate, Innovation, Junshi, Kalos, Kleo, Lee's, Macromoltek, Mateon, Medincell, Modalis, Novartis, Noxopharm, Nuvo, Ocumension, Onxeo, Ostrich, Otsuka, Persephone, Premas, Primmune, Sanbio, Seikagaku, Seneca, Shenogen Pharma, Sirona, Sorrento, Takeda, Ultragenyx, Vaxart, Vir, Viscient, Voltron.
BioWorld Asia
Briefs
Other news to note